Position in MGNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$346,005
+$129,565 QoQ
Shares Held
74,893
0.0% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#50
of 122 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MGNX Over Time
Shares Held
Position Value (USD)
Derivatives in MGNX
reported options exposure · as of Mar 31, 2024CallValue
$7,705,920
CallShares
523,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. MGNX ranks #91 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
328,635 | $43,793,900 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
1,059,730 | $41,287,080 | |
| 3 | ALMS |
Alumis Inc.
|
870,548 | $24,497,220 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
72,842 | $24,386,773 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
388,682 | $22,594,084 | |
| 6 | CLDX |
Celldex Therapeutics, Inc.
|
478,500 | $17,804,985 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
504,559 | $15,555,553 | |
| 8 | RLMD |
Relmada Therapeutics, Inc.
|
2,148,359 | $14,866,644 |
All Filings in MGNX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $346,005 | 74,893 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $216,440 | 74,893 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $120,577 | 74,893 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $134,519 | 80,071 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $96,885 | 80,071 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $101,690 | 80,071 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $260,230 | 80,071 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $263,459 | 80,079 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $850,335 | 200,079 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,683,418 | 318,167 | Shares | Sole | 2024-05-17 | |
| 2024-03-31 | $7,705,920 | 523,500 | Call | Sole | 2024-05-17 | |
| 2023-03-31 | $1,792,500 | 250,000 | Shares | Sole | 2023-05-15 | |
| 2022-03-31 | $1,445,888 | 164,119 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,504,554 | 156,047 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,946,729 | 188,478 | Shares | Sole | 2021-11-15 | |
| 2021-09-30 | $9,339,240 | 446,000 | Call | Sole | 2021-11-15 | |
| 2021-06-30 | $8,058,000 | 300,000 | Call | Sole | 2021-08-18 | |
| 2021-06-30 | $12,344,909 | 459,602 | Shares | Sole | 2021-08-18 | |
| 2021-03-31 | $6,370,000 | 200,000 | Call | Sole | 2021-08-18 | |
| 2021-03-31 | $15,939,937 | 500,469 | Shares | Sole | 2021-08-18 | |
| 2020-03-31 | $2,095,374 | 360,030 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||